Correspondence
Duodeno-jejunal adenocarcinoma and coeliac disease
We read with interest the report by MacGowan et al of two cases of duodenojejunal adenocarcinoma representing a first presentation of coeliac disease. ' We have recently encountered a similar case of coeliac disease presenting initially as a periampullary adenocarcinoma, in which changes of severe villous atrophy and an associated lymphocytic gastritis were present in the Whipple's resection specimen.
A 42 year old woman presented with symptoms and signs of intermittent obstructive jaundice. Endoscopic retrograde cholangiopancreatography revealed a duodenal tumour, biopsies of which confirmed adenocarcinoma. Pancreaticoduodenectomy and cholecystectomy were performed and histology confirmed a poorly differentiated periampullary adenocarcinoma with four positive lymph nodes. In addition, histology of the duodenal mucosa not involved by tumour showed severe villous atrophy with crypt hyperplasia and increased intraepithelial lymphocytes typical of untreated coeliac disease. Histology of the antral portion of the resection specimen showed features of an active lymphocytic gastritis.
The patient subsequently developed profuse malabsorptive diarrhoea with reduced levels of vitamin B 12 and folate. She was put on a gluten free diet and significant weight gain ensued. Repeat distal duodenal and gastric biopsies have shown a marked improvement in villous architecture and resolution of the lymphocytic gastritis.
Of particular interest in this case was the additional finding of a lymphocytic gastritis within the antral gastric component of the Whipple's resection specimen. It is recognised that there is a significant association between coeliac disease and both lymphocytic colitis2 and lymphocytic gastritis,' possibly representing a manifestation of gluten sensitivity at different levels of the gastrointestinal tract. Although it is recognised that the changes of lymphocytic gastritis may be focal, it is possible that resolution of the lymphocytic gastritis in this case represents a response to gluten free diet and this phenomenon merits further study.
This case is an additional example of coeliac disease presenting with a small bowel carcinoma and the findings further highlight the association between coeliac disease and lymphocytic gastritis. The Two points need, perhaps, further clarification. My problem with the term MIN being applicable to junctional naevi is the fact that it is applicable to all junctional naevi, regardless of the presence or absence of atypia. Thus, the distinction between the categories "benign" and "MIN with no microinvasion", as evident from fig 1 in the CRC Panel paper, would not be entirely appropriate.
Perhaps more important than this question of terminology is the more basic biological issue of the concept of invasion in melanocytic tumours. The remarks made in my editorial were not aimed specifically at the CRC Panel's paper. My point can be summarised as follows: as the precursor lesion of invasive melanoma is most commonly a naevus with an intradermal (as well as an intraepithelial) component, the pathogenesis of some melanomas is bound to be different from that of epithelial neoplasms, unless we assume, without proof, that the intradermal component of the naevus is always an innocent bystander, and never plays a role in the pathogenesis of the tumour. Perhaps we have to reconsider the current dogma, which dictates that cutaneous melanoma always arises in the epidermis and that its presence in the dermis results from invasive growth. The fact that the number of purely intradermal primary melanomas is "vanishingly small" does not prove that the intraepithelial component was always first, and the intradermal component develops as a result of "invasive growth".
I feel that we are well advised to exercise some caution when using the concept of early malignancy and early invasion of epithelial neoplasms as the template on which we mould our terminology of melanocytic neoplasms. We have discontinued the use of the term melanocarcinoma, commonly used a few decades ago, but in some ways our concept of melanocytic tumours continues to be related to epithelial neoplasms to a degree that is not really supported by solid data.
As indicated above, this is not a criticism specifically aimed at the paper by the CRC Panel, it is aimed at most of us, including myselfl. However, I am sure we all agree that in science it is never too late to reconsider critically one's beliefs and assumptions.
MIN terminology "Rolling stones gather no moss". Similarly, despite increased verbal support for the term melanocytic intraepidermal neoplasia (MIN), the subject has received little formal published appraisal. For this reason, Professor Mooi's editorial on the diagnosis of thin melanoma is of particular importance.' Astutely, he highlights several significant conceptual and practical drawbacks associated with the term MIN. I share his overall reservations and propose that other considerations should be added to his list.
First, it is essential that adoption of the term MIN only follows extensive international discussion and agreement. The United Kingdom must not go it alone and become isolated.
Second, the scientific and diagnostic basis for radial and vertical growth phases in melanoma must be established beyond rea-
